Aegerion Pharmaceuticals
Aegerion Pharmaceuticals was acquired by Amryt Pharma plc 24 September 2019. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at
7-day free trial · no credit card
Verified contacts
10
available on Kipplo
LinkedIn employees
29
201 to 500 range
Open roles
—
no listings
Distinct roles
9
indexed titles
Tech stack
2
tools in use
Monthly traffic
831
organic / mo
Sign up free to see all 10 verified contacts at Aegerion Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
10 contacts with verified email or phone · masked until revealed.
- CD
Caroline Dash
Regional Clinical Dietitian · Healthcare & Human Services
EmailPhone - JF
James Frigge
Lipid Specialty Manager · Other
EmailPhone - LC
Lisa Collias
Rare Disease Manager · Sales & Business Development
EmailPhone - SR
Syping Roca
Clinical Project Manager · Operations
EmailPhone
Showing 4 of 10 verified contacts
Top roles at Aegerion Pharmaceuticals
9 distinct titles indexed · top 9 shown.
- 2manager
- 1accounts payable payroll manager
- 1clinical project manager
- 1emea senior finance director
- 1executive assistant, business development
- 1lipid specialty manager
- 1program management intern
- 1rare disease manager
- 1regional clinical dietitian
Sign up to unlock all 10 contacts at Aegerion Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 10 verified contacts at Aegerion Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.